治疗儿童多发性硬化症的进展
Rachel Walsh1,2, Tanuja Chitnis1,2
1Division of Child Neurology, Mass General Brigham Pediatric MS Center, Boston, MA 02114, USA.
Children (Basel, Switzerland)
|March 28, 2025
概括
儿科发病多发性硬化症 (POMS) 治疗正在发展,新的疗法对儿童和青少年有希望. 本综述涵盖了关键的临床试验和治疗策略,用于管理这种慢性神经疾病.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 儿科 儿科 儿科
背景情况:
- 儿科发病多发性硬化症 (POMS) 是一种慢性,免疫媒介的中枢神经系统疾病,影响18岁前3-10%的MS患者.
- 大多数儿科MS病例呈现出复发缓解的过程和显著的疾病活性.
- 从历史上看,儿童多发性硬化症的治疗方法是非标签的,成功程度有限.
研究的目的:
- 审查儿童多发性硬化症的治疗进展.
- 讨论新兴治疗方法和单克隆抗体的安全性和有效性.
- 检查POMS患者的治疗策略和考虑因素.
主要方法:
- 在儿科MS的开创性临床试验的叙述性综述.
- 评估包括fingolimod,二甲基 fumarate,特里弗卢诺米德,ocrelizumab和alemtuzumab在内的疗法.
- 对单克隆抗体的安全性和有效性数据的审查.
主要成果:
- 像PARADIGMS,CONNECT,TERIKIDS,OPERETTA I和LEMKIDS这样的种子试验已经提供了针对POMS的特定治疗方法的数据.
- 新兴疗法和单克隆抗体为儿童多发性硬化症管理提供了新的选择.
- 证据支持对不同治疗策略的评估,包括诱导与升级.
结论:
- 随着新的药物批准和临床试验数据,POMS的治疗选择迅速扩大.
- 了解这些治疗方法的安全性,疗效和战略应用对于优化患者护理至关重要.
- 需要进一步的研究和临床经验来完善儿科多发性硬化症的治疗方案.
相关概念视频
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...